Cancer
How Chemotherapy Interferes with the Body’s Internal Clock
The relentless fight against cancer has long been marked by the harsh reality of treatment-related side effects, many of which...
Groundbreaking Clinical Trial Shows Safety and Molecular Insights of Pre- and Post-Surgery Immunotherapy Combo in Operable Mesothelioma Patients
In a pioneering advancement that could reshape the therapeutic landscape for operable mesothelioma, researchers at the Johns Hopkins Kimmel Cancer...
New Study on High-Grade Serous Carcinomas in Cervical Biopsies Supports Removal of Cervical Serous Carcinoma from WHO Classification
In a groundbreaking clinicopathologic study recently published in the Journal of Clinical and Translational Pathology, researchers have shed critical light...
Cancer Cells Exploit Alternative Pathways to Sustain Their Growth
In the ever-evolving landscape of cancer metabolism, new insights often challenge long-standing paradigms about how malignant cells sustain their aggressive...
Tarlatamab Combined with Anti-PD-L1 Shows Promising Safety and Unprecedented Overall Survival as First-Line Maintenance Therapy Following Chemo-Immunotherapy in ES-SCLC
In a significant advancement within the landscape of lung cancer therapeutics, novel clinical data unveiled at the 2025 International Association...
“‘Rogue’ DNA Circles Uncover Earliest Insights into Deadly Brain Cancer Development”
A pioneering international research effort has uncovered how circular, extrachromosomal DNA rings—termed ecDNA—play a critical role in propelling the growth...
Major Data Updates and New Study Broaden the Kids First Data Ecosystem
The Gabriella Miller Kids First Pediatric Research Program (Kids First) at the National Institutes of Health (NIH) has once again...
BMS-986504 Shows Lasting Efficacy in MTAP-Deleted NSCLC, Targeting EGFR and ALK-Positive Tumors
In a groundbreaking development in the fight against non-small cell lung cancer (NSCLC), researchers have unveiled promising results from a...
Phase III Trial Shows Hypofractionated Radiotherapy Plus Chemotherapy Matches Survival Rates and Reduces Toxicity Compared to Conventional Treatment in Limited-Stage SCLC
(Barcelona, Spain — September 8, 2025) — A pivotal multi-center, randomized phase III clinical trial has recently demonstrated that a...
UK Study Finds Lung Cancer Screening Benefits Adults Up to Age 80 Who Are Surgical Candidates
(Barcelona, Spain, September 8, 2025, 10:45 a.m. CEST / UTC +2) — Recent findings presented at the prestigious International Association...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!